Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States; Harvard Stem Cell Institute, Harvard Medical School, Boston, United States
Kimitaka Shibue
Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States; Harvard Stem Cell Institute, Harvard Medical School, Boston, United States
Dario F De Jesus
Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States; Harvard Stem Cell Institute, Harvard Medical School, Boston, United States
Hyunki Kim
Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States; Harvard Stem Cell Institute, Harvard Medical School, Boston, United States
Jiang Hu
Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
Debasish Manna
Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, United States; Divisions of Renal Medicine and Engineering, Brigham and Women’s Hospital, Boston, United States
Bridget Wagner
Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, United States
Amit Choudhary
Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, United States; Divisions of Renal Medicine and Engineering, Brigham and Women’s Hospital, Boston, United States
Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, United States; Harvard Stem Cell Institute, Harvard Medical School, Boston, United States
Pancreatic α-cells secrete glucagon, an insulin counter-regulatory peptide hormone critical for the maintenance of glucose homeostasis. Investigation of the function of human α-cells remains a challenge due to the lack of cost-effective purification methods to isolate high-quality α-cells from islets. Here, we use the reaction-based probe diacetylated Zinpyr1 (DA-ZP1) to introduce a novel and simple method for enriching live α-cells from dissociated human islet cells with ~95% purity. The α-cells, confirmed by sorting and immunostaining for glucagon, were cultured up to 10 days to form α-pseudoislets. The α-pseudoislets could be maintained in culture without significant loss of viability, and responded to glucose challenge by secreting appropriate levels of glucagon. RNA-sequencing analyses (RNA-seq) revealed that expression levels of key α-cell identity genes were sustained in culture while some of the genes such as DLK1, GSN, SMIM24 were altered in α-pseudoislets in a time-dependent manner. In conclusion, we report a method to sort human primary α-cells with high purity that can be used for downstream analyses such as functional and transcriptional studies.